Guangli-KY Corrects Q1 115 IFRSs iXBRL Announcement Information
光麗生技控股公告更正115年第1季IFRSs iXBRL報表中，關於多間被投資子公司的相關資訊與投資損益。
📋 Article Processing Timeline
- 📰 Published: May 15, 2026 at 09:00
- 🔍 Collected: May 16, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 16, 2026 at 17:51 (9h 51m after Collected)
Guangli Biotechnology Holding Co., Ltd. announced a correction to its Q1 115 IFRSs iXBRL financial information. The correction pertains to the 'investee company name, location, and other related information', which was previously omitted or unlisted. The updated report comprehensively details original investment amounts, final shareholding ratios, and recognized investment gains and losses for multiple subsidiaries, including Novel Idea, Taiwan Guangli Industrial, and Alliance Capital. The corrected financial document will be re-uploaded to the Market Observation Post System.